Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Applied DNA Sciences Inc (APDN) USD0.001

Sell:$5.29 Buy:$5.43 Change: $0.23 (4.41%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Sell:$5.29
Buy:$5.43
Change: $0.23 (4.41%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Sell:$5.29
Buy:$5.43
Change: $0.23 (4.41%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Applied DNA Sciences, Inc. (Applied DNA) develops and markets DNA-based technology solutions. The Applied DNA provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets. Applied DNA is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). The Applied DNA products include: Signature Molecular Tags, SigNify, and CertainT. SigNature Molecular Tags provides forensic power and protection for a range of applications. SigNify IF portable DNA readers and SigNify consumable reagent test kits provide real-time authentication of molecular tags in the field and front-line solution for supply chain integrity backed with forensic-level molecular tag authentication. CertainT includes tagging, testing and tracking platforms and solutions, enabling manufacturers, and trade organizations to convey proof of their product claims.

Contact details

Address:
50 Health Sciences Dr
STONY BROOK
11790-3349
United States
Telephone:
+1 (631) 2408800
Website:
www.adnas.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
APDN
ISIN:
US03815U3005
Market cap:
$39.38 million
Shares in issue:
7.49 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • James Hayward
    Chairman of the Board, President, Chief Executive Officer
  • Beth Jantzen
    Chief Financial Officer
  • Judith Murrah
    Chief Operating Officer
  • Clay Shorrock
    Chief Legal Officer and Executive Director
  • Ming-Hwa Liang
    Secretary, Strategic Technology Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.